Panakeia

Next generation multi-omics and biomarker profiling from routine tissue images

London, United Kingdom · Founded 2018 · $3.8M raised

Headquarters
London
Employees
11–50
Founded
2018
Business Model
B2B
Total Funding
$3.8M
Last Round
$3.7M SeedOct 2019
Rounds
2

About

Panakeia is an AI-powered digital pathology company based in London that provides next-generation multi-omics and biomarker profiling directly from routine H&E-stained tissue images. Its platform, PANProfiler, delivers molecular insights in minutes rather than the days or weeks required by traditional physical laboratory tests, enabling faster and more accurate cancer diagnostics. Panakeia partners with leading institutions including Cancer Research UK, King's College London, Tech Nation, and PathLAKE, and serves both hospital and laboratory clinical settings as well as pharmaceutical research teams.

Summary

Panakeia is an Artificial Intelligence company based in London, United Kingdom, founded in 2018. It has raised $3.8M in total across 2 rounds, most recently a $3.7M Seed round in Oct 2019. Investors include Springboard Enterprises and Silicon Roundabout Ventures.

Tech & App Stack

1 technologies & apps tracked

Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.

Sign up to view funding chart

Create a free account to see funding visualizations and detailed round data.

Funding History

Sign up to see all 2 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies